Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Cost of Revenue (2021 - 2024)

Historic Cost of Revenue for Macrogenics (MGNX) over the last 4 years, with Q4 2024 value amounting to $233000.0.

  • Macrogenics' Cost of Revenue rose 4294.48% to $233000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $233000.0, marking a year-over-year decrease of 7001.29%. This contributed to the annual value of $847000.0 for FY2024, which is 3683.36% up from last year.
  • Latest data reveals that Macrogenics reported Cost of Revenue of $233000.0 as of Q4 2024, which was up 4294.48% from $168000.0 recorded in Q3 2024.
  • In the past 5 years, Macrogenics' Cost of Revenue registered a high of $3.0 million during Q3 2022, and its lowest value of $17000.0 during Q1 2021.
  • Moreover, its 4-year median value for Cost of Revenue was $172000.0 (2024), whereas its average is $466750.0.
  • As far as peak fluctuations go, Macrogenics' Cost of Revenue skyrocketed by 71818.18% in 2022, and later crashed by 9717.33% in 2023.
  • Over the past 4 years, Macrogenics' Cost of Revenue (Quarter) stood at $947000.0 in 2021, then plummeted by 87.75% to $116000.0 in 2022, then surged by 40.52% to $163000.0 in 2023, then soared by 42.94% to $233000.0 in 2024.
  • Its last three reported values are $233000.0 in Q4 2024, $168000.0 for Q3 2024, and $176000.0 during Q2 2024.